Результаты поиска

Opportunistic CT for Prediction of Adverse Postoperative Events in Patients with Spinal Metastases.

The purpose of this study was to assess the value of body composition measures obtained from opportunistic abdominal computed tomography (CT) in order to predict hospital length of stay (LOS), 30-day postoperative complications, and reoperations in patients undergoing surgery for spinal metastases. 196 patients underwent CT of the abdomen within three months of surgery for spinal metastases. Automated body composition segmentation and quantifications of the cross-sectional areas (CSA) of abdominal visceral and subcutaneous adipose tissue and abdominal skeletal muscle was performed. From this,

Diffuse Large B-Cell Lymphoma Presenting as an Unusual Paraneoplastic Neurologic Syndrome Affecting the Central and Peripheral Nervous Systems.

A 68-year-old man presented with a two-week history of ascending, symmetric, sensory neuropathy concerning an acute inflammatory demyelinating polyneuropathy that briefly responded to intravenous immunoglobulin (IVIg) therapy. The initial workup was negative for acquired causes. After three months of poor response to standard therapies, he was hospitalized for severe disability, unintentional weight loss, and additional, unexplained neurologic symptoms including cerebellar ataxia, dysarthria, and muscle twitching. Positron emission tomography revealed hypermetabolism isolated to the bone marro

Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration.

Randomised controlled trials commonly use surrogate endpoints to substitute for a target outcome (outcome of direct interest and relevance to trial participants, clinicians, and other stakeholders—eg, all cause mortality) to improve their efficiency (through shorter trial duration, reduced sample size, and thus lower research costs), or for ethical or practical reasons. But reliance on surrogate endpoints can increase the uncertainty of an intervention’s treatment effect and potential failure to provide adequate information on intervention harms, which has led to calls for improved reporting o

European Code Against Cancer, 5th edition - occupational exposures and cancer.

Occupational exposure to cancer-causing agents is a major, yet preventable, contributor to cancer in Europe and globally. In the European Union (EU), cancer is responsible for nearly half of all work-related deaths, underscoring the critical need for prevention measures. Effective strategies typically involve regulatory and workplace measures aimed at reducing or eliminating exposure risks. Raising awareness of hazardous workplace exposures is essential to empower individuals, foster a culture of prevention, and support effective regulation. The 5th edition of the European Code Against Cancer

C-Reactive Protein Level: A Key Predictive Marker of Cachexia in Lymphoma and Myeloma Patients.

BACKGROUND: Cachexia is defined as an involuntary loss of weight, characterized by a loss of skeletal muscle mass with or without fat mass loss. It increases mortality risk and decreases quality of life in patients with lymphoma or myeloma. Early markers of cachexia are not identified. The objective of this work was to identify risk factor of cachexia in a cohort of patients with hematological malignancies to develop strategies to prevent cachexia and its consequences. METHODS: Clinical and biological parameters were collected before and at the end of the treatment. Quantification of weight l

Val103Ile polymorphism of the melanocortin-4 receptor gene (MC4R) in cancer cachexia.

BackgroundAt present pathogenic mechanisms of cancer cachexia are poorly understood. Previous evidence in animal models implicates the melanocortin-4 receptor gene (MC4R) in the development of cancer cachexia. In humans, MC4R mutations that lead to an impaired receptor function are associated with obesity; in contrast, the most frequent polymorphism (Val103Ile, rs2229616; heterozygote frequency approximately 2%) was shown to be negatively associated with obesity. We tested if cancer patients that are homo-/heterozygous for the Val103Ile polymorphism are more likely to develop cachexia and/or a

Ассоциация " Myokines " , " Инфламация " и " Состояние питания пациентов с множественным склерозом " .

Последние исследования свидетельствуют о том, что при прогрессивном множественном склерозе (MS) - воспалительном и дегенеративном заболевании центральной нервной системы - биологические пути, связанные с этим воздействием, остаются недостаточно понятными. Изменения в весе тела, будь то избыточный вес или недостаточный вес, а также изменения в жире и мышечной ткани, наряду с хроническим воспалением, могут способствовать болезни и влиять на ее ход.ЦЕЛЬ: Это тематическое исследование было направлено на измерение подстрекательских маркеров и уровней миокина (миостатина и ирисина), нейротрофическог

Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study.

BACKGROUND: Cachexia is a metabolic syndrome that affects up to 50-80% of cancer patients. The pathophysiology is characterized by a variable combination of reduced food intake and abnormal metabolism, including systemic inflammation and negative protein and energy balance. Despite its high clinical significance, defined diagnostic criteria and established therapeutic strategies are lacking. The 'omics' technologies provide a global view of biological systems. We hypothesize that blood-based metabolomics might identify findings in cachectic patients that could provide clues to gain knowledge o

Oral chemotherapy agents in cats: clinical uses, administration and side effects.

PRACTICAL RELEVANCE: Cancer is a very common disease in cats, and many feline patients will require chemotherapy as part of their treatment plan, either as a sole agent or as part of multimodality therapy. Although some general practitioners might be reluctant to undertake injectable chemotherapy, oral chemotherapy may feel like a more acceptable treatment option to manage in practice. CLINICAL CHALLENGES: The small body size of many cats means that tablet sizes made for the human market are less appropriate, which creates dosing challenges. The administration of oral medication can also be a

Совпадение в полном тексте источника
… Steps for minimising exposure via a patient’s waste products and other bodily fluids can be found in the ‘Health and safety guidelines for chemotherapeutic agents’ box. … As such, a ‘chemo barrier’ period of 7 days is generally recommended, during which time owners should adhere to health and safety guidelines regarding the handling of waste products. …

Connection between nutrition and oncology in dogs and cats: perspectives, evidence, and implications-a comprehensive review.

Oncology has become one of the most influential and studied areas in both human and companion animal health. In veterinary practice, cancer represents a significant challenge, especially concerning cats and dogs. Nutrition plays a crucial role in the management of oncology patients in veterinary medicine; however, is often nonspecific and reliant on data from other species and diseases, highlighting the need for a comprehensive review of the latest developments in this field. Since the intricate relationship between nutrition and cancer encompasses various aspects, this review therefore intend

Myokines in cancer: bridging molecular mechanisms to biomarker discovery and therapeutic innovation.

Exercise can regulate the physiological functions of the body by inducing the secretion of myokines, which are bioactive factors mainly secreted by muscle cells. This review classifies myokines based on their functional characteristics, including metabolic regulation (such as myostatin, interleukin-6), neuroregulation (brain-derived neurotrophic factor), cell proliferation/differentiation regulation (myogenic proteins), immune regulation (tumor necrosis factor- alpha), and factors involved in angiogenesis and extracellular matrix remodeling (such as connective tissue growth factor).Cancer, as

Climate footprint of industry-sponsored in-human clinical trials: life cycle assessments of clinical trials spanning multiple phases and disease areas.

OBJECTIVE: This study aims to calculate the global warming potential, in carbon dioxide (CO2) equivalent emissions, from all in-scope activities involved in phase 1, 2, 3 and 4 clinical trials spanning multiple disease areas. DESIGN: The study design involved a retrospective analysis of completed clinical trials. SETTING: Select set of seven clinical trials conducted between 2018 and 2023 and sponsored by Johnson & Johnson Innovative Medicine: TMC114FD1HTX1002, 77242113PSO2001, 42756493BLC2002, 54767414MMY3012, VAC18193RSV3006, R092670PSY3016 and 28431754DIA4032 PARTICIPANTS: While participa

Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration.

Randomised controlled trials often use surrogate endpoints to substitute for a target outcome (an outcome of direct interest and relevance to trial participants, clinicians, and other stakeholders—eg, all cause mortality) to improve efficiency (through shortened duration of follow-up, reduced sample size, and lower research costs), and for ethical or practical reasons. However, their use has a fundamental limitation in terms of uncertainty of the intervention effect on the target outcome and limited information on potential intervention harms. There have been increasing calls for improved repo

Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice.

Chemotherapy is frequently accompanied by several side effects, including nausea, diarrhea, anorexia and fatigue. Evidence from ours and other groups suggests that chemotherapy can also play a major role in causing not only cachexia, but also bone loss. This complicates prognosis and survival among cancer patients, affects quality of life, and can increase morbidity and mortality rates. Recent findings suggest that soluble factors released from resorbing bone directly contribute to loss of muscle mass and function secondary to metastatic cancer. However, it remains unknown whether similar mech

The bone-muscle connection in breast cancer: implications and therapeutic strategies to preserve musculoskeletal health.

Breast cancer and its therapies frequently result in significant musculoskeletal morbidity. Skeletal complications include bone metastases, pain, bone loss, osteoporosis, and fracture. In addition, muscle loss or weakness occurring in both the metastatic and curative setting is becoming increasingly recognized as systemic complications of disease and treatment, impacting quality of life, responsiveness to therapy, and survival. While the anatomical relationship between bone and muscle is well established, emerging research has led to new insights into the biochemical and molecular crosstalk be

Воздействие физических упражнений на мышечную силу и характеристики ревматических заболеваний и саркопсии: Протокол исследования по вопросам ухода за мышечными мышцами (C4M).

ЦЕЛЬ: слабость мышечных мышц характерна для ревматоидного артрита (RA), остеоартрита (OA) и саркопсии (SARC). Упражнения на выносливость могут улучшить митохондриальную функцию и окислительную способность, в то время как считается, что упражнения на прочность стимулируют синтез белка миофибрилла. Цель этого исследования заключается в сопоставлении последствий упражнений на прочность и выносливость и в изучении связи между мышечными характеристиками и результатами упражнений у пациентов с RA, OA и SARC. Мы предполагаем, что реакция на выносливость и сильные упражнения у пациентов с мышечной сла

Unleashing the Impact of Exosomes Derived from Human Placental Mesenchymal Stem Cells (hPMSCs) on U-266 Myeloma Cell Line.

Multiple myeloma (MM) is a malignancy of plasma cells, terminally differentiated B cells, with complications like hypercalcemia, renal failure, anemia, and bone disease, which are also known as CRAB criteria. MM develops from monoclonal gammopathy of unknown significance (MGUS), a pre-malignant plasma cell dyscrasia. Over some time, MGUS has the potential to progress into smoldering multiple myeloma (SMM), which can evolve into MM. MM rarely progresses into plasma cell leukemia (PCL), a condition in which malignant plasma cells no longer stay in the bone marrow niche and circulate in the perip

Treatment of early-stage diabetic nephropathy with Siddha drug Sirupeelai Kudineer: A case series.

Diabetic Nephropathy is one of the major microvascular complications of Diabetes Mellitus, which can be detected in the earlier stage by investigating urinary microalbumin excretion levels and estimating ACR and GFR. Early treatment can delay or prevent the progression of diabetic Nephropathy. Monoherbal Siddha formulation Sirupeelai Kudineer indicated for the complications of Diabetes Mellitus is selected for this Case study. The efficiency of the drug was assessed by measuring the change in renal function throughout the treatment period and the KD QOL assessment. Four patients presented with

Совпадение в полном тексте источника
… It can be taken as an indicator of removing metabolic waste products from blood [ 8 ]. …

Коррозионное поведение Incoloy_800H, Hasteloy ¶G35> и 316L бесшовной стали в смеси фтористых молотков FLINAK и ее паров

Данная статья рассматривает результаты эксперимента по коррозии, который исследует переходную зону между нижней и верхней областями образца. В этом эксперименте нижняя половина поверхности образца подвергается воздействию расплавленной соли, а верхняя половина поверхности образца подвергается воздействию паров, генерируемых расплавленной солью FLiNak. Для коррозионного эксперимента были выбраны сплавы Incoloy®800H и Hastelloy®G35® и нержавеющая сталь 316L на основе их содержания хрома. Эксперимент был проведен при температуре 600 °C в течение 100 часов. Результаты эксперимента показывают, что

Связанные с возрастом различия в структуре Choroid Plexus ассоциируются с изменениями в когниции.

Хороиды-плексус (CP) играют важнейшую роль в поддержании гомеостазиза центральной нервной системы (КНС), производстве цереброспинной жидкости и регулировании поступления конкретных веществ в ЦНС из крови. Дефункция ХП была связана с различными неврологическими и психическими расстройствами, включая болезнь Альцгеймера, болезнь Паркинсона и множественный склероз. В этом исследовании изучается взаимосвязь между структурной целостностью ХП и когнитивным снижением нормативных показателей старения с использованием структурных и передовых методов магнитного резонансного изображения, включая объем ХП

Совпадение в полном тексте источника
… Additionally, the CP structure facilitates bulk removal of waste products through the glymphatic system and plays pivotal roles in regulating chemical balance, ionic composition, immunosurveillance and influencing circadian rhythmicity ( 3 – 5 ). … Furthermore, the CP’s role in regulating the entry of substances into the CNS and facilitating the removal of waste products from the brain may be compromised with aging ( 48 , 49 , 57 , 58 ), leading to the accumulation of toxic substances and exacerbating cognitive decline. …